> top > docs > PMC:3586680 > spans > 136-257 > annotations

PMC:3586680 / 136-257 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T593 116-118 NNP denotes WW
T592 114-115 . denotes .
T591 109-114 NNS denotes drugs
T590 97-108 JJ denotes therapeutic
T589 93-96 CC denotes and
T588 91-92 -RRB- denotes )
T587 88-91 NNP denotes TMZ
T586 87-88 -LRB- denotes (
T585 74-86 VB denotes temozolomide
T584 71-73 TO denotes to
T583 60-70 NN denotes resistance
T582 57-59 TO denotes to
T581 55-56 , denotes ,
T580 51-55 NN denotes part
T579 48-50 IN denotes in
T578 46-47 , denotes ,
T577 36-46 VB denotes contribute
T576 33-35 TO denotes to
T575 25-32 VBZ denotes appears
T574 21-24 CC denotes and
T573 19-20 -RRB- denotes )
T572 15-19 NNS denotes GBMs
T571 14-15 -LRB- denotes (
T570 0-13 NNS denotes glioblastomas
R284 T571 T572 punct (,GBMs
R285 T572 T570 appos GBMs,glioblastomas
R289 T576 T577 aux to,contribute
R290 T577 T575 xcomp contribute,appears
R291 T578 T577 punct ",",contribute
R292 T579 T575 prep in,appears
R293 T580 T579 pobj part,in
R294 T581 T575 punct ",",appears
R295 T582 T583 aux to,resistance
R297 T584 T585 aux to,temozolomide
R298 T585 T583 advcl temozolomide,resistance
R299 T586 T587 punct (,TMZ
R300 T587 T585 appos TMZ,temozolomide
R301 T588 T587 punct ),TMZ
R302 T589 T585 cc and,temozolomide
R303 T590 T591 amod therapeutic,drugs
R304 T591 T585 conj drugs,temozolomide

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T535 74-92 Entity denotes temozolomide (TMZ)
T526 97-114 Entity denotes therapeutic drugs
T523 88-91 Entity denotes TMZ

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T206 116-118 JJ denotes WW
T205 109-114 NN denotes drugs
T204 97-108 JJ denotes therapeutic
T203 93-96 CC denotes and
T202 91-92 -RRB- denotes )
T201 88-91 NN denotes TMZ
T200 87-88 -LRB- denotes (
T199 74-86 NN denotes temozolomide
T198 71-73 TO denotes to
T197 60-70 NN denotes resistance
T196 57-59 TO denotes to
T195 55-56 -COMMA- denotes ,
T194 51-55 NN denotes part
T193 48-50 IN denotes in
T192 46-47 -COMMA- denotes ,
T191 36-46 VB denotes contribute
T190 33-35 TO denotes to
T189 25-32 VB denotes appears
T188 21-24 CC denotes and
T187 19-20 -RRB- denotes )
T186 15-19 NN denotes GBMs
T185 14-15 -LRB- denotes (
T184 0-13 NN denotes glioblastomas
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic